Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 8/2011

01-08-2011 | Endocrine Tumors

Does Mediastinal Extension of the Goiter Increase Morbidity of Total Thyroidectomy? A Multicenter Study of 19,662 Patients

Authors: Mario Testini, MD, Angela Gurrado, MD, Nicola Avenia, MD, Rocco Bellantone, MD, Antonio Biondi, MD, PhD, Paolo Brazzarola, MD, Filippo Calzolari, MD, PhD, Giuseppe Cavallaro, MD, PhD, Giorgio De Toma, MD, Pietro Guida, PhD, Germana Lissidini, MD, PhD, Michele Loizzi, MD, Celestino Pio Lombardi, MD, Giuseppe Piccinni, MD, Piero Portincasa, MD, PhD, Lodovico Rosato, MD, Nora Sartori, MD, Chiara Zugni, MD, Francesco Basile, MD

Published in: Annals of Surgical Oncology | Issue 8/2011

Login to get access

Abstract

Purpose

To compare the outcome in patients with cervical goiters and cervicomediastinal goiters (CMGs) undergoing total thyroidectomy using the cervical or extracervical approach.

Methods

This was a retrospective study conducted at six academic departments of general surgery and one endocrine-surgical unit in Italy. The study population consisted of 19,662 patients undergoing total thyroidectomy between 1999 and 2008, of whom 18,607 had cervical goiter (group A) and 1055 had CMG treated using a cervical approach (group B, n = 986) or manubriotomy (group C, n = 69). The main parameters of interest were symptoms, gender, age, operative time, duration of drain, length of hospital stay, malignancy and outcome.

Results

A split-sternal approach was required in 6.5% of cases of CMG. Malignancy was significantly more frequent in group B (22.4%) and group C (36.2%) versus group A (10.4%; both P < .001), and in group C versus group B (P = .009). Overall morbidity was significantly higher in groups B + C (35%), B (34.4%) and C (53.5%) versus group A (23.7%; P < .001). Statistically significant increases for group B + C versus group A were observed for transient hypocalcemia, permanent hypocalcemia, transient recurrent laryngeal nerve (RLN) palsies, permanent RLN palsies, phrenic nerve palsy, seroma/hematoma, and complications classified as other. With the exception of transient bilateral RLN palsy, all of these significant differences between group B + C versus group A were also observed for group B versus group A.

Conclusions

Symptoms, malignancy, overall morbidity, hypoparathyroidism, RLN palsy and hematoma are increased in cases of substernal goiter.
Literature
1.
Haller A. Disputationes anatomicae selectae. Gottingen, Holland: Vandenhoeck, 1749:96.
2.
Huins CT, Georgalas C, Mehrzad H, Tolley NS. A new classification system for retrosternal goitre based on a systematic review of its complications and management. Int J Surg. 2008;6:71–6.PubMedCrossRef
3.
Cougard P, Matet P, Goudet P, et al. Les goitre plongeants: 218 cas operas. Ann Endocrinol (Paris). 1992;53:230–5.
4.
Vadasz P, Kotsis L. Surgical aspects of 175 mediastinal goiters. Eur J Cardiothorac Surg. 1998; 14:393–7.PubMedCrossRef
5.
Chow TL, Chan TT, Suen DT, Chu DW, Lam SH. Surgical management of substernal goitre: local experience. Hong Kong Med J. 2005;11:360–5.PubMed
6.
deSouza FM, Smith PE. Retrosternal goiter. J Otolaryngol. 1983;12:393–6.PubMed
7.
Goldenberg IS, Lindskog GE. Differential diagnosis, pathology, and treatment of substernal goiter. JAMA. 1957;163:527–9.
8.
Sanders LE, Rossi RL, Shahian DM, Williamson WA. Mediastinal goiters: the need for an aggressive approach. Arch Surg. 1992;127:609–13.PubMed
9.
Katlic MR, Wang C, Grillo HC. Substernal goiter. J Otolaryngol. 1992;21:165–70.
10.
Pieracci FM, Fahey TJ 3rd. Substernal thyroidectomy is associated with increased morbidity and mortality as compared with conventional cervical thyroidectomy. J Am Coll Surg. 2007;205:1–7.PubMedCrossRef
11.
Singh B, Lucente FE, Shaha AR. Substernal goiter: a clinical review. Am J Otolaryngol. 1994;15:409–16.PubMedCrossRef
12.
Shen WT, Kebebew E, Duh QY, Clark OH. Predictors of airway complications after thyroidectomy for substernal goiters. Arch Surg. 2004;138:656–60.
13.
Ozdemir A, Hasbahceci M, Hamaloglu E, Oznec A. Surgical treatment of substernal goiter. Int Surg. 2000;85:194–7.PubMed
14.
Hedayati N, McHenry C. The clinical presentation and operative management of nodular and diffuse substernal thyroid disease. Am Surg. 2002;68:245–51.PubMed
15.
Rodriguez JM, Hernandez Q, Pinero A, et al. Substernal goiter: clinical experience of 72 cases. Ann Otol Rhinol Laryngol. 1999;108:501–4.PubMed
16.
Moran JC, Singer JA, Sardi A. Retrosternal goiter: a six-year institutional review. Am Surg. 1998;64:889–93.
17.
Erbil Y, Bozbora A, Barbaros U, Ozarmagan S, Azezli A, Molvalilar S. Surgical management of substernal goiters: clinical experience of 170 cases. Surg Today. 2004;34:732–6.PubMedCrossRef
18.
Chauhan A, Serpell JW. Thyroidectomy is safe and effective for retrosternal goitre. ANZ J Surg. 2006;76:238–42.PubMedCrossRef
19.
Netterville JL, Coleman SC, Smith JC, Smith MM, Day TA, Burkey BB. Management of substernal goiter. Laryngoscope. 1998;108:1611–7.PubMedCrossRef
20.
White ML, Doherty GM, Gauger PG. Evidence-based surgical management of substernal goiter. World J Surg. 2008;32:1285–300.PubMedCrossRef
21.
Hall TS, Caslowitz P, Propoper C, Smith GW. Substernal goiter versus intrathoracic aberrant thyroid: a critical difference. Ann Thorac Surg. 1988;46:684–6.PubMedCrossRef
22.
Sancho JJ, Pascual-Damieta M, Pereira JA, Carrera MJ, Fontané J, Sitges-Serra A. Risk factors for transient vocal cord palsy after thyroidectomy. Br J Surg. 2008;95:961–7.PubMedCrossRef
23.
Testini M, Rosato L, Avenia N, et al. The impact of single parathyroid gland autotransplantation during thyroid surgery on postoperative hypoparathyroidism: a multicenter study. Transplant Proc. 2007;39:225–30.PubMedCrossRef
24.
Thompson NW, Reeve T. Complications of thyroid surgery: how to avoid them, how to manage them, and observation on their possible effect on the whole patient. World J Surg. 2000;24:971–5.PubMedCrossRef
25.
Al-Suliman NN, Ryttov NF, Qvist N, Blichert-Toft M, Graversen HP. Experience in a specialist thyroid surgery unit: a demographic study, surgical complications and outcome. Eur J Surg. 1997;163:13–20.PubMed
26.
Maruotti RA, Zannini P, Viani MP, Voci C, Pezzuoli G. Surgical treatment of substernal goiters. Int Surg. 1991;76:12–7.PubMed
27.
28.
Monchik JM, Materazzi G. The necessity for a thoracic approach in thyroid surgery. Arch Surg. 2000;135:467–71.PubMedCrossRef
29.
Hsu B, Reeve TS, Guinea AI, Robinson B, Delbridge L. Recurrent substernal nodular goiter: incidence and management. Surgery. 1996;120:1072–5.PubMedCrossRef
30.
Hashmi SM, Premachandra DJ, Bennet AM, Parry W. Management of retrosternal goitres: results of early surgical intervention to prevent airway morbidity, and a review of the English literature. J Laryngol Otol. 2006;120:644–9.PubMedCrossRef
31.
de Perrot M, Fadel E, Mercier O, et al. Surgical management of mediastinal goiters: when is a sternotomy required? Thorac Cardiovasc Surg. 2007;55:39–43.PubMedCrossRef
32.
Grainger J, Saravanappa N, D’Souza A, Wilcock D, Wilson PS. The surgical approach to retrosternal goiters: the role of computerized tomography. Otolaryngol Head Neck Surg. 2005;132:849–51.PubMedCrossRef
33.
Testini M, Nacchiero M, Miniello S, et al. Management of retrosternal goiters: experience of a surgical unit. Int Surg. 2005;90:61–5.PubMed
34.
Burns P, Doody J, Timon C. Sternotomy for substernal goitre: an otolaryngologist’s perspective. J Laryngol Otol. 2007;11:1–5.
35.
Page C, Strunski V. Cervicothoracic goiter: an anatomical or radiological definition? Report of 223 surgical cases. J Laryngol Otol. 2007;121:1083–7.PubMed
36.
Ahmed ME, Ahmed EO, Mahadi SI. Retrosternal goiter: the need for median sternotomy. World J Surg. 2006;30:1945–8.PubMedCrossRef
37.
Sancho JJ, Kraimps JL, Sanchez-Blanco JM, et al. Increased mortality and morbidity associated with thyroidectomy for intrathoracic goiters reaching the carina tracheae. Arch Surg. 2006:141:82–5.PubMedCrossRef
38.
Thompson NW, Olsen WR, Hoffman GL. The continuing development of the technique of thyroidectomy. Surgery. 1973;73:913.PubMed
39.
Zambudio AR, Rodriguez J, Riquelme J, Soria T, Canteras M, Parrilla P. Prospective study of postoperative complications after total thyroidectomy for multinodular goiters by surgeons with experience in endocrine surgery. Ann Surg. 2004; 240:18–25.PubMedCrossRef
40.
Bhattacharyya N, Fried MP. Assessment of the morbidity and complications of total thyroidectomy. Arch Otolaryngol Head Neck Surg. 2002;128:389–92.PubMed
41.
McHenry CR, Piotrowski JJ. Thyroidectomy in patients with marked thyroid enlargement: airway management, morbidity, and outcome. Am Surg. 1994;60:586–91.PubMed
42.
Arici C, Dertsiz L, Altunbaş H, Demircan A, Emek K. Operative management of substernal goiter: analysis of 52 patients. Int Surg. 2001;86:220–4.PubMed
43.
Testini M, Marzaioli R, Lissidini G, et al. The effectiveness of FloSeal® matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study. Langenbecks Arch Surg. 2009;394:837–42.PubMedCrossRef
44.
Testini M, Nacchiero M, Piccinni G, et al. Total thyroidectomy is improved by loupe magnification. Microsurgery. 2004;24:39–42.PubMedCrossRef
45.
Armitage P, Berry G. Statistical methods in medical research. 3rd ed. Oxford: Blackwell Science; 1994.
46.
Dawson B, Trapp RG. Basic and clinical biostatistics. 3rd ed. New York: McGraw-Hill; 2001.
47.
Armour RH. Retrosternal goitre. Br J Surg. 2000;87:519.
48.
49.
Testini M, Piccinni G, Lissidini G, Nacchiero M. The lifting of substernal goitres using a Fogarty catheter. Ann R Coll Surg Engl. 2005;87:63–4.PubMed
50.
Pandya S, Sanders LE. Use of a Foley catheter in the removal of a substernal goiter. Am J Surg. 1998;175:155–7.PubMedCrossRef
51.
Allo MD, Thompson NW. Rationale for the operative management of substernal goiters. Surgery. 1983;94:969–77.PubMed
52.
Saha SP, Rogers AG, Early GF, Nachbauer C, Baker M. Surgical management of intrathoracic goiter. J Ky Med Assoc. 1997;95:421–3.PubMed
53.
Rios A, Rodriguez JM, Balsalobre MD, Torregrosa NM, Tebar FJ, Parrilla P. Results of surgery for toxic multinodular goiter. Surg Today. 2005;35:901–6.PubMedCrossRef
54.
Thomusch O, Machens A, Sekulla C, et al. Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg. 2000;24:1335–41.PubMedCrossRef
55.
Liu Q, Djuricin G, Prinz RA. Total thyroidectomy for benign thyroid disease. Surgery. 1998;123:2–7.PubMedCrossRef
56.
Zedenius J, Wadstrom C, Delbridge LW. Routine autotransplantation of at least one parathyroid gland during total thyroidectomy may reduce permanent hypoparathyroidism to zero. Aust N Z J Surg. 1999;69:794–9.PubMedCrossRef
57.
Gauger PG, Reeve TS, Wilkinson M, Delbridge LW. Routine parathyroid autotransplantation during total thyroidectomy: the influence of technique. Eur J Surg. 2000;166:605–9.PubMedCrossRef
58.
Harness JK, Fung L, Thompson NW, Burney RE, McLeod MK. Total thyroidectomy: complications and technique. World J Surg. 1986;10:781–6.PubMedCrossRef
59.
de Roy van Zuidewijin DB, Songun I, Kievit J, van de Velde CJ. Complications of thyroid surgery. Ann Surg Oncol. 1995;2:56–60.CrossRef
60.
Wingert DJ, Frisen SR, Lliopoulos JI, Pierce GE, Thomas JH, Hermreck AS. Post-thyroidectomy hypocalcemia. Incidence and risk factors. Am J Surg. 1986;152:606–10.PubMedCrossRef
61.
Moalem J, Suh I, Duh QY. Treatment and prevention of recurrence of multinodular goiter: An evidence-based review of the literature. World J Surg. 2008;32:1301–12.PubMedCrossRef
62.
Muller PE, Jakoby R, Heinert G, Spelsberg F. Surgery for recurrent goitre: its complications and their risk factors. Eur J Surg. 2001;167:816–21.PubMedCrossRef
63.
Erbil Y, Bozbora A, Yanik BT, Ozbey N, Salmaslioglu A, Ozarmagan S. Predictive factors for recurrent non-toxic goitre in an endemic region. J Laryngol Otol. 2007;121:231–6.PubMedCrossRef
64.
Deviditis RA, Guimãraes AV, Machado PC, Suehara AN, Noda E. Surgical treatment of the substernal goitre. Int Surg. 1999;84:190–2.
65.
Wilson RB, Erskine C, Crowe PJ. Hypomagnesemia after thyroidectomy: prospective study. World J Surg. 2000;24:722–6.PubMedCrossRef
66.
Shemen L, Ko W. Current technique for resection of mediastinal goiter. Ear Nose Throat J. 2006;85:609–11.PubMed
67.
Ben Nun A, Soudack M, Best L-A. Retrosternal thyroid goiter: 15 years experience. Isr Med Assoc J. 2006;8:106–9.PubMed
68.
Donnellan KA, Pitman KT, Cannon CR, Replogle WH, Simmons JD. Intraoperative laryngeal nerve monitoring during thyroidectomy. Arch Otolaryngol Head Neck Surg. 2009;135:1196–8.PubMedCrossRef
69.
Terris DJ, Anderson SK, Watts TL, Chin E. Laryngeal nerve monitoring and minimally invasive thyroid surgery: complementary technologies. Arch Otolaryngol Head Neck Surg. 2007;133:1254–7.PubMedCrossRef
70.
Rosato L, Avenia N, Bernante P, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg. 2004;28:271–6.PubMedCrossRef
71.
Burkey SH, van Heerden JA, Thompson GB, Grant CS, Scleck CD, Farley DR. Reexploration for symptomatic hematomas after cervical exploration. Surgery. 2001;130:914–20.PubMedCrossRef
72.
Defechereux T, Rinken F, Maweja S, Hamoir E, Meurisse M. Evaluation of the ultrasonic dissector in thyroid surgery. A prospective randomised study. Acta Chir Belg. 2003;103:274–7.PubMed
73.
Meurisse M, Defechereux T, Maweja S, Degaugue C, Vandelaer M, Hamoir E. Evaluation of Ultracision ultrasonic dissector in thyroid surgery. Prospective randomized study. Ann Chir. 2000;125:468–72.PubMedCrossRef
74.
Ortega J, Sala C, Flor B, Lledo S. Efficacy and cost-effectiveness of the UltraCision harmonic scalpel in thyroid surgery: an analysis of 200 cases in a randomized trial. J Laparoendosc Adv Surg Tech A. 2004;14:9–12.PubMedCrossRef
75.
Siperstein AE, Berber E, Morkoyun E. The use of the harmonic scalpel vs. conventional knot tying for vessel ligation in thyroid surgery. Arch Surg. 2002;137:137–42.PubMedCrossRef
76.
Kilic M, Keskek M, Ertan T, Yoldas O, Bilgin A, Koc M. A prospective randomized trial comparing the harmonic scalpel with conventional knot tying in thyroidectomy. Adv Ther. 2007;24:632–8.PubMedCrossRef
77.
Shemen L. Thyroidectomy using the harmonic scalpel. Analysis of 105 consecutive cases. Otolaryngol Head Neck Surg. 2002;127:284–8.PubMedCrossRef
78.
Oz MC, Cosgrove DM 3rd, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann Thorac Surg. 2000;69:1376–82.PubMedCrossRef
79.
Weaver FA, Hood DB, Zatina M, Messina L, Badduke B. Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg. 2002;16:286–93.PubMedCrossRef
80.
Shah PJ, Bright T, Singh SS, et al. Large retrosternal goitre: a diagnostic and management dilemma. Heart Lung Circ. 2006;15:151–2.PubMedCrossRef
81.
Buckley JA, Stark P. Intrathoracic mediastinal thyroid goiter: imaging manifestation. Am J Roentgenol. 1999;173:471–5.
82.
Nakahara H, Noguchi S, Muratami N, et al. Gadolinium-enhanced MR imaging of thyroid and parathyroid masses. Radiology. 1997;202:765–72.PubMed
83.
Tezuka M, Murata Y, Ishida R, Ohashi I, Hirata Y, Shibuya H. MR imaging of the thyroid: correlation between apparent diffusion coefficient and thyroid gland scintigraphy. J Magn Reson Imaging. 2003;17:163–9.PubMedCrossRef
84.
Cooper JC, Nakielny R, Talbot CH. The use of computed tomography in the evaluation of large multinodular goitres. Ann R Coll Surg Engl. 1991;73:32–5.PubMed
85.
Brown LR, Aughenbaugh GL. Masses of the anterior mediastinum: CT and MR imaging. Am J Roentgenol. 1991;157:1171–80.
Metadata
Title
Does Mediastinal Extension of the Goiter Increase Morbidity of Total Thyroidectomy? A Multicenter Study of 19,662 Patients
Authors
Mario Testini, MD
Angela Gurrado, MD
Nicola Avenia, MD
Rocco Bellantone, MD
Antonio Biondi, MD, PhD
Paolo Brazzarola, MD
Filippo Calzolari, MD, PhD
Giuseppe Cavallaro, MD, PhD
Giorgio De Toma, MD
Pietro Guida, PhD
Germana Lissidini, MD, PhD
Michele Loizzi, MD
Celestino Pio Lombardi, MD
Giuseppe Piccinni, MD
Piero Portincasa, MD, PhD
Lodovico Rosato, MD
Nora Sartori, MD
Chiara Zugni, MD
Francesco Basile, MD
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 8/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1596-4

Other articles of this Issue 8/2011

Annals of Surgical Oncology 8/2011 Go to the issue

Endocrine Tumors

Central Lymph Node Metastasis of Unilateral Papillary Thyroid Carcinoma: Patterns and Factors Predictive of Nodal Metastasis, Morbidity, and Recurrence

Translational Research and Biomarkers

Identification of the Coexisting HER2 Gene Amplification and Novel Mutations in the HER2 Protein-Overexpressed Mucinous Epithelial Ovarian Cancer

Gastrointestinal Oncology

Childbearing After Hyperthermic Intraperitoneal Chemotherapy: Results From an International Survey

Hepatobiliary Tumors

Antiangiogenic Therapy for Primary Liver Cancer: Correlation of Changes in Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Tissue Hypoxia Markers and Clinical Response

Hepatobiliary Tumors

Clinical Significance of Alpha-Fetoprotein mRNA in Peripheral Blood in Liver Resection for Hepatocellular Carcinoma

Translational Research and Biomarkers

Elevated Expression of the Stem Cell Marker CD133 Associated with Line-1 Demethylation in Hepatocellular Carcinoma